Sponsors and institutions using this program to document rater competency, inter-rater reliability and educational compliance for studies, programs and clinical trials: You may need additional documentation beyond a completion certificate (WHICH HAVE BEEN KNOWN TO BE USED IN FRAUD AND ABUSE CASES IN HEALTHCARE AND CLINICAL RESEARCH) to fulfill requirements of regulatory agencies. Certificate records should be checked against centralized repositories / databases in order to verify their authenticity. Neither HealthCarePoint.com nor any BlueCloud network member is responsible for any liabilities resulting from the improper use or improper documentation required to properly document competency, inter-rater reliability or evidence based education for clinical trial programs. Please call our program administrator if you require additional information.
THIS PROGRAM IS FREE OF CHARGE TO ALL HEALTHCARE PROFESSIONALS!
This page is where you will find your program for your to 'Enroll' according to your hospital requirements. Once enrolled, the system will dynamically place the chosen activity under your 'Assigned' activities where you can begin the chosen program.
The program consists of a self-paced Instruction-Demonstration module and the certification modules. The NIH Stroke Scale International (NIHSSI) Test contains 6 sections, each containing a single patient interview. You must score all 6 patients at >84 out of 90 items correct to achieve certification. As of June 19, 2018 – certification is VALID FOR UP TO ONE -1- YEAR FROM THE DATE OF COMPLETION when used in clinical research or, more than one year, time line controlled by the local SOP requirements of your organization - recommended 2 years when used for healthcare purposes only.
According to the disclosure policy of the Academy, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.
This educational activity does not include discussion of drugs or devices or uses of drugs and devices that have not been approved by the FDA. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy, or American Nurses Credentialing Council’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Marian Emr, Walter J. Koroshetz, Patrick Lyden, John Marler, Margo Warren – reported no relevant financial relationships to disclose at the time this online training was developed.
Yu D. Cheng, MD, PhD (University of California at San Diego Stroke Center), Kama Z. Goluma, MD (University of California at San Diego); Judith A. Hinchey, MD (New England Medical Center); Mary A. Kalafut, MD (Scripps Clinic); Brett C. Meyer, MD (University of California at San Diego); Karen S. Rapp, RN, BSN, CCRC (University of California at San Diego Stroke Center); Sandi G. Shaw, RN, BSN (University of Texas Medical School at Houston); Sidney Starkman (University of California at Los Angeles) reported they had no relevant financial relationships at the time the training was developed.
Thomas G. Brott, MD (Mayo Medical School—Jacksonville); Larry B. Goldstein, MD (Duke University Medical Center): James C. Grotta, MD (University of Texas Medical School at Houston); Christopher A. Lewandowski, MD (Henry Ford Hospital); Judith A. Spilker, RN (University of Cincinnati)-reported they had no relevant financial relationships to disclose at the time the training was developed.
Harold P. Adams, Jr, MD (University of Iowa): Consultant: Merck (adjudicate end points) and Medtronic (safety board)
Joseph P. Broderick, MD (University of Cincinnati): Consultant: Ono Pharmaceuticals (chair, Data Safety Monitoring Committee), Novo Nordisk (steering committee); Grant support: AstraZeneca, EKOS Corporation (PI), Genentech; Honoraria for speaking: Boehringer Ingelheim; Scientific Advisor: Genentech;
K. Michael Welch, MD (Finch University of Health Sciences--The Chicago Medical School) Advisor and grant support: Pfizer; Lecture grant (migraine and stroke): GlaxoSmithKline.
American Academy of CME: John JD Juchniewicz, MCIS, CCMEP, Natalie Kirkwood, RN, BS, JD (lead nurse planner), Sondra Moylan, MS, RN - have no relevant financial relationships to disclose.